cadralazine has been researched along with Heart Failure in 2 studies
cadralazine: structure given in first source
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical and haemodynamic effects of a single oral dose of cadralazine were studied in 22 patients with an average age of 64 years presenting with severe chronic cardiac failure." | 7.67 | [Treatment of chronic cardiac failure with cadralazine. Short- and medium-term results]. ( Camous, JP; Drici, M; Gibelin, P; Leborgne, L; Lloret, JL; Mélia, P; Morand, P, 1987) |
| "The clinical and haemodynamic effects of a single oral dose of cadralazine were studied in 22 patients with an average age of 64 years presenting with severe chronic cardiac failure." | 3.67 | [Treatment of chronic cardiac failure with cadralazine. Short- and medium-term results]. ( Camous, JP; Drici, M; Gibelin, P; Leborgne, L; Lloret, JL; Mélia, P; Morand, P, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibelin, P | 2 |
| Lloret, JL | 1 |
| Drici, M | 1 |
| Leborgne, L | 1 |
| Camous, JP | 2 |
| Mélia, P | 1 |
| Morand, P | 2 |
| Profit-Degoul, I | 1 |
| Baudouy, M | 1 |
2 other studies available for cadralazine and Heart Failure
| Article | Year |
|---|---|
[Treatment of chronic cardiac failure with cadralazine. Short- and medium-term results].
Topics: Aged; Aged, 80 and over; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pyridazines | 1987 |
[Efficacy and tolerability of a delayed-action vasodilator agent, cadralazine, in severe chronic cardiac failure].
Topics: Aged; Chronic Disease; Delayed-Action Preparations; Female; Heart Failure; Hemodynamics; Humans; Mal | 1986 |